1.. Introduction {#s1}
================

When studies report on multiple outcomes for each patient, a joint, multivariate meta-analysis (multiple outcomes multivariate meta-analysis, MOMA) can be used to incorporate all possible correlations in order to perform a simultaneous synthesis of all data for all outcomes. The effects of disregarding all possible correlations by performing a series of independent, univariate analyses have been explored and may include a loss of precision and an increase of selective reporting bias ([@KXU030C10]; [@KXU030C16]). There are two types of correlations to consider: within-study correlations of the estimated relative treatment effects on the multiple outcomes, reflecting the fact that the same patients report on each of these outcomes and between-study correlations of the true relative treatment effects on the different outcomes, reflecting the way these true effects depend on each other when measured in different setting. Many estimation methods for MOMA models have been suggested in recent years, both in a frequentist and a Bayesian setting ([@KXU030C8]; [@KXU030C17]; [@KXU030C26]; for reviews, see [@KXU030C7]; [@KXU030C14]).

Currently available models for performing an MOMA of randomized trials focus on the case of meta-analysis for studies that compare only two treatments and report on multiple, possibly correlated outcomes. As in practice, many alternative treatments exist for the same condition, network meta-analysis (NMA) is increasingly gaining in popularity as it allows the synthesis of data over a network of treatments compared in studies for a certain outcome ([@KXU030C4]; [@KXU030C11]; [@KXU030C20]; [@KXU030C22]). It is therefore desirable to extend MOMA methods for multiple-treatment comparisons. To our knowledge, there is no general model available for performing a joint, multiple-outcome NMA for multi-arm studies, that incorporates both within- and between-studies correlations (multiple outcomes network meta-analysis, MONMA), for binary, continuous and time-to-event outcomes. In this paper, we propose two different modeling approaches to perform such an analysis. The first approach is based on making a set of simplifying assumptions to model both within- and between-studies correlation coefficients. The second approach is a generalization of a bivariate model proposed by Riley *and others* that allows for a single correlation coefficient to model the overall correlation, an amalgam of the within- and between-study correlations ([@KXU030C19]). We fit the models in a Bayesian framework that offers flexibility in incorporating prior beliefs and allows for a straightforward inclusion of studies that do not report on all outcomes, as well as accounting for uncertainty in parameter estimates.

The paper is structured as follows: in Section 2, we describe the data we used to illustrate our methods. In Section 3, we present the two approaches and discuss the technicalities of fitting the models. In Section 4, we apply the methods to our data to produce estimates for outcome-specific relative treatment effects and evaluate the relative ranking of the treatments for each outcome. In Section 5, we present our conclusions, discuss the limitations of the models and suggest areas for future research.

2.. Example: the acute mania dataset {#s2}
====================================

The dataset we used as an example is a network of 68 studies comparing 13 active antimanic drugs and placebo for acute mania ([@KXU030C2]). The majority of the studies had two arms (50 studies) and there were 18 three-arm studies. The primary outcomes of interest were efficacy and treatment discontinuation (acceptability) after 3 weeks. Acceptability was estimated as the number of patients leaving the study early for any reason, before or after having a response to the treatment, out of the total number of randomized patients. All-cause discontinuation from allocated treatment may be due to a number of reasons, such as adverse effects, inefficacy, other reasons not related to treatment (e.g. moving away, protocol violation), or a combination of the above. Efficacy was reported either as dichotomous outcome (number of patients who responded to treatment, defining response as a reduction of at least 50% in manic symptoms from baseline to week 3) or as continuous outcome (mean change scores on a standardized rating scale for mania after 3 weeks). Although we recognize that outcome dichotomization may lose some information, in this paper we use data on efficacy as a dichotomous outcome as it may be easier to interpret clinically and allows us to illustrate our methodology for two related binary outcomes, a frequent scenario encountered by researchers. Only a few patients did not provide data for response to treatment and their outcome was coded as treatment failure; an imputation assumption that has been shown to be sensible ([@KXU030C23]). Among the included studies, only 65 contributed with data for at least one of the outcomes of interest: 18 studies (28%) did not report usable data on response, while only one study did not report information on the number of dropouts (1.5%). Efficacy and acceptability outcomes are generally expected to be negatively correlated; although early full response to the treatment may be a cause for leaving the study prematurely, more often it is reasonable to assume that more efficacious treatments are associated with a lower dropout rate. Within-study correlations were not reported in any of the studies and individual patient data (IPD) which could be used to estimate within-study correlations were not available. The dataset included a total of 69 head-to-head comparisons for response and 100 for dropout. In Section 1 of the [supplementary material available at *Biostatistics* online](http://biostatistics.oxfordjournals.org/lookup/suppl/doi:10.1093/biostatistics/kxu030/-/DC1), we provide a table with all head-to-head comparisons for each outcome, along with the odds ratios and their 95% confidence interval. The initial analysis consisted of two independent network meta-analyses, one for each outcome ([@KXU030C2]). As both outcomes are crucially important for clinical decision making, the ranking of the treatments was presented for both efficacy and acceptability in a two-dimensional scatter plot (Figure 6 in Cipriani *and others*) so that efficacious treatments with high tolerability could be identified. This is a suboptimal approach and the rankings of the treatments for each outcome can be better estimated jointly in a MONMA model to account for the correlation in the outcomes. This is especially important here as 19 studies provide data on only one of the two outcomes, and MONMA can "borrow strength" from these studies even for the missing outcomes.

3.. Methods {#s3}
===========

First, we revise the models used for performing an MOMA when only two treatments are compared. We then generalize these methods for a network of interventions that includes multi-arm studies.

3.1. Pairwise multivariate meta-analysis of multiple outcomes {#s3a}
-------------------------------------------------------------
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3.2. NMA for two correlated outcomes {#s3b}
------------------------------------

The two models described in the previous section can be easily extended to perform a meta-analysis for a network of treatments, if all included studies have just two treatments arms. These models, however, cannot handle the case of studies comparing more than two treatments.

In this section, we present two models for performing an NMA of studies with multiple arms reporting on two correlated outcomes, generalizing the models presented in Section 3.1. The outcomes can be binary (and relative treatment effect can be measured as log odds ratios or log risk ratios), continuous (effects measured as mean differences or standardized mean differences) or time to event (effects measured as log hazard ratios). Note that in order to use the standardized mean difference for a continuous outcome a large sample approximation is required. For more details, see Section 3 of [supplementary material available at *Biostatistics* online](http://biostatistics.oxfordjournals.org/lookup/suppl/doi:10.1093/biostatistics/kxu030/-/DC1). In the acute mania example, the outcomes are identified as the binary response to the treatment ($\documentclass[12pt]{minimal}
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### 3.2.1. Model 1: Simplifying the variance--covariance matrices {#s3b1}
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One technical implication that comes up is that the positive definiteness of the within-study variance--covariance matrix is not guaranteed for three-arm studies. The estimated matrix $\documentclass[12pt]{minimal}
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### 3.2.2. Model 2: Extending the alternative MOMA model {#s3b2}

In this section, we discuss a second method for performing an MONMA, by extending Riley\'s *and others* alternative model ([@KXU030C19]). The model described in Section 3.1 is $\documentclass[12pt]{minimal}
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4.. Application to acute mania dataset: NMA for response and dropout {#s4}
====================================================================

4.1. Model fit and analysis plan {#s4a}
--------------------------------

We fit both models in a Bayesian framework using the OpenBUGS software. Prior distributions must be assigned to all model parameters. The parameters $\documentclass[12pt]{minimal}
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4.2. Results {#s4b}
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In Figure [1](#KXU030F1){ref-type="fig"}, we present the summary odds ratios for both outcomes for each treatment versus placebo and for models I, II.b, and III. In Section 8 of [supplementary material available at *Biostatistics* online](http://biostatistics.oxfordjournals.org/lookup/suppl/doi:10.1093/biostatistics/kxu030/-/DC1), we present the results from fitting each model in detail. The multivariate approach has a minimal effect on the summary results for the dropout outcome compared with the univariate. That is expected ([@KXU030C17]) since this outcome was reported in all studies except one, and thus inferences do not gain much through the joint analysis in terms of the posterior estimates and precision for this outcome. In contrast, the posterior summary ORs for the response to treatment outcome have considerable gain in precision when we use a multivariate rather than univariate model. This gain arises because 28% of the studies did not report on response, and thus the multivariate models additionally borrow strength from the correlated dropout outcome in these studies ([@KXU030C17]). The gain in precision is larger as within-study correlation coefficient moves away from zero; the decrease in the width of the confidence intervals of the ORs compared with the results from the univariate approach is on average 8.4% for analysis II.a, 12% for II.b, 12.1% for II.c, 8.2% for II.d, and 10.8% for model III. Note that apart from differences in precision gain there are small changes in the point estimates for most odds ratios among the MONMA models (see Section 8 of [supplementary material available at *Biostatistics* online](http://biostatistics.oxfordjournals.org/lookup/suppl/doi:10.1093/biostatistics/kxu030/-/DC1)). Fig. 1.Summary odds ratios for response and dropout, for active treatment versus placebo. The thick lines correspond to model I (univariate model), the slim lines to model II.b (MONMA model assuming strong correlation coefficient $\documentclass[12pt]{minimal}
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In Figure [2](#KXU030F2){ref-type="fig"}, we present the relative ranking of treatments for response and dropout, for models I, II.b and III, based on the SUCRA value for each outcome. Treatments near the upper right corner are the best when both acceptability and efficacy outcomes are considered jointly important; those near the bottom left corner (dark areas of the plots) are the worst. Note that Gabapentin is not present in the graph, since it was only reported for dropout. Regardless of the choice of model, OLA has the highest ranking across both outcomes jointly. However, the ranking of some other treatments is affected by the choice of multivariate rather than univariate, especially in regard the response outcome which (through correlation) is able to borrow strength from the more complete acceptability outcome. This use of additional information leads to (small) differences in the multivariate and univariate mean posterior estimates and precision of the summary ORs for response, and this has an impact on the relative ranking of the treatments for this outcome. For example, Carbamazepine ranks as the best treatment in terms of response with the univariate model but it falls to the fourth place when we consider a within-study correlation coefficient $\documentclass[12pt]{minimal}
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}{}$\rho =-0.7$\end{document}$. Fig. 2.Ranking of antimanic drugs for response and acceptability. Treatments located in the darker (brighter) areas of the plots have the lowest (highest) rankings. ARI, aripiprazole; ASE, asenapine; CBZ, carbamazepine; VAL, divalproex; HAL, haloperidol; LAM, lamotrigine; LIT, lithium; OLZ, olanzapine; PBO, placebo; QTP, quetiapine; PAL, paliperidone; TOP, topiramate; ZIP, ziprasidone.

5.. Discussion {#s5}
==============

We have developed two models for meta-analyzing evidence from multi-arm studies reporting multiple correlated outcomes in a network of interventions. Our models require minimum aggregated-level information, are independent of the mechanism that induces the correlations, and are applicable to any NMA with multiple continuous, dichotomous, or time-to-event outcomes; that is the majority of the NMA applications ([@KXU030C15]).

The set of models we present provides a unified way of handling multiple outcomes in the presence of multi-arm studies using only a handful of parameters. Choice between the two models may be informed by various factors. The first MONMA model accounts for within-study variances (sampling error), between-study variance (heterogeneity) as well as within and between-studies correlation. The second (alternative) model includes both within- and between-study variances, but uses a single correlation parameter $\documentclass[12pt]{minimal}
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}{}$\rho ^{h}$\end{document}$. Thus, the second model can be viewed as an approximation of the first MONMA model, with the latter having a more detailed likelihood structure. The second model can be used in the common situation when within-study covariances (the $\documentclass[12pt]{minimal}
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}{}$\kappa $\end{document}$ parameters in ([3.6](#KXU030M3x6){ref-type="disp-formula"})) are not available from all studies or cannot be reliably obtained from external data or expert opinion. Ease of application is another consideration when choosing between the two models. The first model is more difficult to implement as it has a richer structure and investigators need to ensure the positive definiteness of the variance--covariance matrix.

Although NMA is an increasingly popular technique, few attempts have been made so far to combine it with multiple outcomes models. Our models are more general than those currently available in the literature. [@KXU030C27] presented an MONMA model applicable to NMA with two-arm studies only. [@KXU030C6] presented methods for synthesizing multiple outcomes for multiple competing treatments, but their approach completely ignores within-study correlations and we do not recommend it. [@KXU030C13] presented an approach for modeling multiple outcomes reported over multiple follow-up times; their models are applicable only for repeated measurements for a binary outcome and requires arm-level data.

Our models perform better than the univariate one in terms of precision; this gain, however, does not come without a cost. The complexity of the multivariate analysis is an important limitation, and the difficulty in implementing the models rises as the number of outcomes of interest or the number of arms of the studies in the network grows. When only a small number of studies do not report on all outcomes, the gain in precision can be trivial, rendering the use of multivariate methods redundant. The models are also limited by the assumptions we used to simplify the structure of the variance--covariance matrices; in [supplementary material available at *Biostatistics* online](http://biostatistics.oxfordjournals.org/lookup/suppl/doi:10.1093/biostatistics/kxu030/-/DC1), we offer guidance for the case the analyst is unwilling to employ these assumptions. The gain in power by joint modeling of correlated outcomes is sometimes too small to justify the increased modeling complexity ([@KXU030C24]). Multivariate meta-analysis might provide more powerful results when several studies provide only one of the outcomes and in the presence of selective outcome reporting ([@KXU030C3]; [@KXU030C10]). We recommend to consider both multivariate and univariate approaches, to ascertain if clinical conclusions about the ranking of treatments for each outcome remain consistent under different model assumptions.

Despite their limitations the two presented models are to our knowledge the first attempts for meta-analyzing data from networks of interventions comprising multi-arm studies that report on multiple correlated outcomes. [@KXU030C5] have developed a framework that utilizes expert clinical opinion about quantities easily understood by clinicians (such as proportions) to impute unreported correlation parameters. Their method is applicable only for binary outcomes measured with odds ratios. In the present approach, we provide two general models for all types of outcomes assuming that the within-study correlations are known or directly informed by external evidence (model 1) or completely unknown (model 2). Finally since MONMA is a new, largely unexplored area, there are still many open areas for research. A possible extension would be to include IPD, either exclusively or in a combination with aggregated data. Furthermore, our models could be implemented in popular statistical software making MONMA more easily accessible to review authors.
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